Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
| Image |  |
|---|---|
| Description | scientific article published on 23 February 2022 |
| Author/s |
author: Ravindra Ganesh John C O'Horo |
| Publication date | February 23, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |